IMGN Gross Margin

The Gross Margin of ImmunoGen Inc (IMGN) is 99.82%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

IMGN Gross Margin - Historical Value

Date	Value
2022-12-31	99.82%

IMGN Gross Margin - Peers Comparison

Ticker	Name	Value
GBIO	Generation Bio Co	7775.20%
KROS	Keros Therapeutics Inc	7775.20%
VRTX	Vertex Pharmaceuticals Inc	86.11%
REPL	Replimune Group Inc	7775.20%
950160.KQ	Kolon TissueGene Inc	11.72%
950220.KQ	Neoimmunetech Inc	7775.20%
CYTK	Cytokinetics Inc	7775.20%
MRNA	Moderna Inc	70.06%
QURE	Uniqure NV	32.42%
950200.KQ	Psomagen Inc	23.13%
ALEC	Alector Inc	7775.20%
BLUE	bluebird bio Inc	-6.65%
DMTK	DermTech Inc	1.80%
MCRB	Seres Therapeutics Inc	7775.20%
ABBV	Abbvie Inc	69.99%
GILD	Gilead Sciences Inc	78.26%
KRYS	Krystal Biotech Inc	93.09%
NRIX	Nurix Therapeutics Inc	7775.20%
REGN	Regeneron Pharmaceuticals Inc	87.01%
RGNX	Regenxbio Inc	59.72%
ALVR	Allovir Inc	7775.20%
STTK	Shattuck Labs Inc	7775.20%
YMAB	Y-mAbs Therapeutics Inc	82.89%
AMGN	Amgen Inc	61.53%
KURA	Kura Oncology Inc	7775.20%
OCGN	Ocugen Inc	7775.20%
OLMA	Olema Pharmaceuticals Inc	7775.20%
SGMO	Sangamo Therapeutics Inc	7775.20%
VBIV	VBI Vaccines Inc	-44.06%
ZYME	Zymeworks Inc	7775.20%
CCCC	C4 Therapeutics Inc	7775.20%
KRON	Kronos Bio Inc	7775.20%
PMVP	PMV Pharmaceuticals Inc	7775.20%